Leerink Partnrs Has Strong Estimate for Immunome Q2 Earnings
Immunome, Inc. (NASDAQ:IMNM – Free Report) – Analysts at Leerink Partnrs increased their Q2 2025 earnings estimates for shares of Immunome in a research report issued to clients and investors on Monday, May 12th. Leerink Partnrs analyst A. Berens now anticipates that the company will earn ($0.59) per share for the quarter, up from their […]
Immunome, Inc. (NASDAQ:IMNM – Free Report) – Analysts at Leerink Partnrs increased their Q2 2025 earnings estimates for shares of Immunome in a research report issued to clients and investors on Monday, May 12th. Leerink Partnrs analyst A. Berens now anticipates that the company will earn ($0.59) per share for the quarter, up from their […]
